{"id":"W4310985942","doi":"10.1186/s13195-022-01110-8","title":"Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease","year":2022,"lang":"en","type":"review","venue":"Alzheimer s Research & Therapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Ontario Brain Institute; Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institute of General Medical Sciences; Genentech; F. Hoffmann-La Roche","keywords":"Medicine; Drug development; Clinical trial; Disease; Context (archaeology); Population; Asymptomatic; Monoclonal antibody; Immunology; Drug; Pathology; Internal medicine; Pharmacology; Antibody; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006562918,0.0004135896,0.0004875854,0.00099308,0.0001003735,0.0005961478,0.000344362,0.0005371333,0.001165859],"category_scores_gemma":[0.0008053404,0.00008940713,0.0004438651,0.0005545555,0.0002148638,0.0007516831,0.0002362953,0.0007090502,0.0006831947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003487738,"about_ca_system_score_gemma":0.0005994759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003972332,"about_ca_topic_score_gemma":0.0008360345,"domain_scores_codex":[0.9997419,0.00007350103,0.00004716846,0.00003322655,0.0000845523,0.00001974158],"domain_scores_gemma":[0.9996794,0.0001403406,0.00006537838,0.000006892499,0.00008344384,0.00002451745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002564902,0.00004876828,0.0006970144,0.01575996,0.0001512559,0.0003930523,0.00008030338,0.0003719155,0.006851813,0.001879828,0.0296513,0.9438583],"study_design_scores_gemma":[0.00006124511,0.0004253549,0.002283904,0.004001113,0.0003069469,0.004220618,0.00004200296,0.0001908603,0.00369538,0.0009516972,0.9837981,0.00002287633],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001255744,0.9949078,0.0006110191,0.0007945833,0.0003803763,0.00002434371,0.00005875393,0.00002536865,0.001942056],"genre_scores_gemma":[0.008614404,0.9872508,0.0007722523,0.001211526,0.000578478,0.00003416591,0.0001224313,0.00000482247,0.001411168],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001165859,"threshold_uncertainty_score":0.00390023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1676447400402152,"score_gpt":0.4495101518988833,"score_spread":0.2818654118586681,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}